Tetragon Partners GP Ltd 13F holdings, Q3 2025
Holdings as of September 30, 2025 · filings on SEC EDGAR · latest filing →
Tetragon Partners GP Ltd disclosed 43 US equity positions worth $688.6m in its Q3 2025 13F filing. The largest position was PATH at 32.9% of the reported book, followed by ALIBABA GROUP HLDG LTD and KGEI. Against the Q2 2025 filing, it opened 12 new positions, added to 13 and reduced 9 among the top 43 holdings.
What did Tetragon Partners GP Ltd own in Q3 2025? Top 43 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2025 |
|---|---|---|---|---|---|---|---|
| 1 | PATH UIPATH INC | Technology | 32.9% | $226.8m | 16,950,000 | 24% | added |
| 2 | ALIBABA GROUP HLDG LTD | 25.4% | $174.8m | 95,000,000 | -5% | reduced | |
| 3 | KGEI KOLIBRI GLOBAL ENERGY INC | 5.7% | $39.2m | 7,070,568 | 0% | held | |
| 4 | LITHIUM ARGENTINA AG | 3.6% | $24.6m | 27,109,000 | 63% | added | |
| 5 | LYFT LYFT INC | Technology | 3.2% | $22.0m | 1,000,000 | 0% | held |
| 6 | CABLE ONE INC | 3.0% | $20.8m | 21,255,000 | – | new | |
| 7 | PROGRESS SOFTWARE CORP | 3.0% | $20.6m | 20,500,000 | – | new | |
| 8 | OATLY GROUP AB | 2.7% | $18.4m | 20,020,027 | 0% | held | |
| 9 | CXM SPRINKLR INC | Technology | 2.5% | $17.0m | 2,200,000 | 0% | held |
| 10 | AUTL AUTOLUS THERAPEUTICS PLC | Healthcare | 2.2% | $15.5m | 9,500,000 | 0% | held |
| 11 | WK WORKIVA INC | Technology | 1.9% | $12.9m | 150,000 | 0% | held |
| 12 | FIRST MAJESTIC SILVER CORP | 1.2% | $8.0m | 7,500,000 | 0% | held | |
| 13 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 1.1% | $7.9m | 303,600 | -4% | reduced |
| 14 | CELCUITY INC | 1.1% | $7.4m | 5,550,000 | – | new | |
| 15 | TARS TARSUS PHARMACEUTICALS INC | Healthcare | 1.1% | $7.4m | 125,000 | -50% | reduced |
| 16 | ANNX ANNEXON INC | Healthcare | 0.9% | $6.4m | 2,112,455 | -25% | reduced |
| 17 | HYG ISHARES TR | 0.9% | $5.9m | 72,961 | 6% | added | |
| 18 | AXSM AXSOME THERAPEUTICS INC | Healthcare | 0.8% | $5.6m | 46,456 | 12% | added |
| 19 | PHVS PHARVARIS N V | 0.7% | $4.9m | 194,612 | 3% | added | |
| 20 | SRRK SCHOLAR ROCK HLDG CORP | Healthcare | 0.6% | $4.4m | 117,882 | 14% | added |
| 21 | TECX TECTONIC THERAPEUTIC INC | Healthcare | 0.6% | $3.8m | 243,728 | 7% | added |
| 22 | AMLX AMYLYX PHARMACEUTICALS INC | Healthcare | 0.5% | $3.5m | 258,242 | 18% | added |
| 23 | MBX MBX BIOSCIENCES INC | Healthcare | 0.5% | $3.1m | 177,840 | – | new |
| 24 | IMVT IMMUNOVANT INC | Healthcare | 0.4% | $3.0m | 188,379 | 27% | added |
| 25 | DYN DYNE THERAPEUTICS INC | Healthcare | 0.4% | $2.8m | 223,181 | 61% | added |
| 26 | ARWR ARROWHEAD PHARMACEUTICALS IN | Healthcare | 0.4% | $2.8m | 81,841 | – | new |
| 27 | ALKS ALKERMES PLC | Healthcare | 0.4% | $2.7m | 89,612 | 473% | added |
| 28 | ABVX ABIVAX SA | 0.4% | $2.5m | 30,000 | – | new | |
| 29 | SNOW SNOWFLAKE INC | Technology | 0.3% | $2.3m | 10,000 | 0% | held |
| 30 | ACAD ACADIA PHARMACEUTICALS INC | Healthcare | 0.3% | $1.8m | 86,071 | -47% | reduced |
| 31 | HBM HUDBAY MINERALS INC | Basic Materials | 0.3% | $1.8m | 117,500 | 10% | added |
| 32 | CCJ CAMECO CORP | Energy | 0.2% | $1.3m | 16,015 | -17% | reduced |
| 33 | RLAY RELAY THERAPEUTICS INC | Healthcare | 0.2% | $1.2m | 223,123 | -68% | reduced |
| 34 | AM6 AMICUS THERAPEUTICS INC | 0.1% | $955.2k | 121,212 | – | new | |
| 35 | KRYS KRYSTAL BIOTECH INC | Healthcare | 0.1% | $859.7k | 4,870 | – | new |
| 36 | TECK TECK RESOURCES LTD | Basic Materials | 0.1% | $793.0k | 18,068 | 184% | added |
| 37 | KROS KEROS THERAPEUTICS INC | Healthcare | 0.1% | $680.3k | 43,000 | -66% | reduced |
| 38 | LAR LITHIUM ARGENTINA AG | 0.1% | $668.0k | 200,000 | – | new | |
| 39 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 0.1% | $533.0k | 17,718 | – | new |
| 40 | WBI WATERBRIDGE INFRASTRUCTURE L | 0.1% | $504.4k | 20,000 | – | new | |
| 41 | NXE NEXGEN ENERGY LTD | Energy | 0.1% | $375.9k | 42,000 | – | new |
| 42 | DIANA SHIPPING INC | 0.0% | $22.8k | 233,400 | -23% | reduced | |
| 43 | SONDER HOLDINGS INC | 0.0% | $204 | 18,898 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.